-
Ipsen Pharma
- Vice-President Global Marketing Aesthetic Medicine
Boulogne-Billancourt
2011 - maintenant
• Define Long term strategy & vision for aesthetic medicine through active life cycle management and new NME development
• Synergize global action with Alliances in order to maximize Dysport business
• Assess global/regional/local performance
• Initiate Partnership with Filorga for Russia
-
Ipsen
- Intercontinental Region - Marketing Director
Boulogne-Billancourt
2007 - 2011
• Effective “Transversal” Management – Local/Region/Global
• Design Marketing Strategy and budget that support business needs : Double digit growth of Dysport in aesthetic indications
• Develop tools (dashboard, monthly report) & process (guidance) to monitor performance and key actions
• Implement global marketing actions, plans and follow-up that foster business initiatives/sharing of experience and value marketing expertise
-
Ipsen
- Country Liaison Manager - North Africa, DOM-TOM, Indochina
Boulogne-Billancourt
2006 - 2007
• Create a Representative Office in Algeria and an Affiliate in Tunisia for Ipsen
• Algeria: Annual Business growth +30% through better targeting for Decapeptyl & primary care products prioritization
-
Ipsen
- International Project Manager
Boulogne-Billancourt
2005 - 2006
• Ensure strategy implementation of endocrinology franchise in Benelux, Nordic countries & Eastern Europe
• Lead Smecta new aroma project to drive gastroenterology franchise growth.
-
Ipsen
- China Medico Marketing Director
Boulogne-Billancourt
2003 - 2005
• Marketing Organization Transformation
• Identify growth opportunities : maximize resource allocation to full speed Diphereline launch & Initiate Smecta new aroma development
• Develop and implement a full campaign Ethical/OTC/DTC for Smecta
• Contribute to build KOL relationship and recognition of Ipsen among scientific community
-
Ipsen
- General Manager Vietnam Laos Cambodia
Boulogne-Billancourt
2001 - 2002
• People management (60 headcounts) & Reorganization
• Renegotiate agreement with distributor partners in Vietnam and Cambodia
• Business development : initiate contact with Cephalon for Spasfon & Fonzylane
• Effectively achieved target over 120% despite of generics
-
Fournier Pharma
- Marketing et Vente
1995 - 2001
Jan 1995 – September 2001: Fournier Pharma : Key Achievements
Taiwan : Country Manager (December 1999 - September 2001)
• Actively participated in Hospital tenders in key medical centers
• Closely involved in NHI price application.
• Recommendation on partnership for out-licensing with Tanabe
Canada: Market Research Manager (November 1997 - September 1998)
• Provided information, quantitative and qualitative risk assessment analysis and objective recommendations which guide the strategy and identify future business opportunities.
Canada: Product Manager Associate Lipidil Micro (October 1998 - November 1999)
• Develop and implemented a full campaign material for pharmacy, customer mailings and an in-house generic.
• Prepared the new positioning and strategy of new formulation of Fenofibrate against generics
Vietnam: Country Manager (January 1995 - October 1997)
• Effectively multiplied sales by over 5 times from 95 to 97 (2.5 million FRF to 18 million FRF in 1997)
• Launched Arphos (Top 5 products in 1998) and OTC campaign of Urgo (Currently the top brand bandages in Vietnam)
• Fournier Pharma Top performing country as the fastest growing country in 1997
